Arcadia Biosciences
NASDAQ: RKDADallas, US · Delaware corporation
Founders & leadership
TJ
Thomas J. SchaeferExecutive Officer, Director
MT
Matthew T PlavanExecutive Officer
UG
Uday GargDirector
RK
Rajendra KetkarExecutive Officer, Director
ER
Eric RayDirector
DC
Deborah CarosellaDirector
GD
Gregory D. WallerDirector
LS
Lilian Shackelford MurrayDirector
AY
Amy YoderDirector
AD
Albert D. BollesDirector
KC
Kevin ComcowichDirector
Competitors · 6
by search overlapby Catepillar21 shared keywords
Mapquest18 shared keywordsProvider of geographical information systems and services; acquired by America Online.
Czytaj więcej17 shared keywords
Diabetes Prevention Program16 shared keywords
Robinhood16 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TradingView15 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with Arcadia Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$4MraisedJun 2026 · 5 investors · Other TechnologyRule 506(b)
▶$4MraisedJun 2026 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Amy YoderDirector
- Lilian Shackelford MurrayDirector
- Gregory D WallerDirector
- Kevin ComcowichDirector
- Thomas J. SchaeferExecutive Officer, Director
- Offering amount
- $11.4M
- Amount sold
- $4M
- Sales commissions
- $395K
- Placement agents
- H.C. Wainwright & Co, LLC
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedJan 2026 · 3 investors · Other TechnologyRule 506(b)
▶$2.1MraisedJan 2026 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Deborah CarosellaDirector
- Gregory D. WallerDirector
- Lilian Shackelford MurrayDirector
- Amy YoderDirector
- Thomas J. SchaeferExecutive Officer, Director
- Albert D. BollesDirector
- Kevin ComcowichDirector
- Offering amount
- $6M
- Amount sold
- $2.1M
- Sales commissions
- $145.7K
- Placement agents
- H.C. Wainwright & Co, LLC
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedFeb 2021 · 26 investors · Other TechnologyRule 506(b)
▶$25MraisedFeb 2021 · 26 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin ComcowichDirector
- Albert D BollesDirector
- Lilian Shackelford MurrayDirector
- Gregory D WallerDirector
- Amy YoderDirector
- Matthew T PlavanExecutive Officer, Director
- Pam HaleyExecutive Officer
- Offering amount
- $25M
- Amount sold
- $25M
- Sales commissions
- $1.8M
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedApr 2018 · 2 investors · Other TechnologyRule 506(b)
▶$10MraisedApr 2018 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew T PlavanExecutive Officer
- Amy YoderDirector
- Gregory D WallerDirector
- Kevin ComcowichDirector
- Uday GargDirector
- Rajendra KetkarExecutive Officer, Director
- Eric RayDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Finders' fees
- $700K
- Placement agents
- H.C. Wainwright & Co. LLC
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Agriculture (USDA) | Phase I | 2017 | $100K |
| Department of Agriculture (USDA) | Phase II | 2016 | $600K |
| Department of Agriculture (USDA) | Phase I | 2016 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2015 | $1.3M |
| Department of Agriculture (USDA) | Phase I | 2015 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2013 | $689.5K |
| National Science Foundation | Phase I | 2013 | $150K |
| Department of Agriculture (USDA) | Phase I | 2013 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2011 | $874.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $144.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2009 | $855.6K |
| Department of Agriculture (USDA) | Phase I | 2007 | $79.9K |
| Department of Agriculture (USDA) | Phase I | 2006 | $79.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2005 | $98.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
- Arcadia Biosciences has filed a notice of an exempt offering of securities to raise $11,417,964.00 in New Funding. - intelligence360intelligence360.news · 2026
- RKDA Secures $4 Million in Private Placement Funding | BioPharmaWbiopharmawatch.com · 2026
- Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options | Quiver Quantitativequiverquant.com · 2026
- Wellness products maker Arcadia Biosciences lines up $4M in fundingstocktitan.net · 2026

